Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer

NCT03617913 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03617913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03617913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
September 19, 2018
Completion date
July 27, 2020
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder carcinoma infiltrating the muscle of the bladder wall, stage ii bladder cancer ajcc v8, stage ii renal pelvis cancer ajcc v8, stage ii ureter cancer ajcc v8, stage ii urethral cancer ajcc v8, stage iii bladder cancer ajcc v8, stage iii renal pelvis cancer ajcc v8, stage iii ureter cancer ajcc v8, stage iii urethral cancer ajcc v8, stage iiia bladder cancer ajcc v8, stage iiib bladder cancer ajcc v8, urethral urothelial carcinoma